Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)
All MBC
Hormone Receptor Positive (ER+ and/or PR+)
- Predicting Response to Treatment with an AI and Palbociclib for HR+ Advanced Breast Cancer
- Palbociclib With Fulvestrant for ER+, HER2- Advanced Breast Cancer
- G1T48 for Advanced ER+ HER2- Breast Cancer
- Fulvestrant and Venetoclax for ER+, HER2- Advanced Breast Cancer
- Immunotherapy and Radiation Therapy for ER+ HER2- Metastatic Breast Cancer
- Immunotherapy and Halaven for HER2 Negative Metastatic Breast Cancer
- PF-06873600 for Metastatic HER2-Negative Breast Cancer
- A166 for HER2 Positive and HER2 Low Expression Advanced Breast Cancer
HER2 positive (HER2+)
Triple Negative
- A Vaccine Plus Chemotherapy or Targeted Therapy in Advanced Triple Negative Breast Cancer
- Opdivo plus Xeloda After Surgery for Triple Negative Metastatic Breast Cancer
- Immunotherapy for Advanced Triple Negative Breast Cancer
- Immunotherapy and Halaven for HER2 Negative Metastatic Breast Cancer
- PF-06873600 for Metastatic HER2-Negative Breast Cancer
- A166 for HER2 Positive and HER2 Low Expression Advanced Breast Cancer
Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.
Last Modified on August 25, 2020
